Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 116 articles: HTML format

Single Articles

April 2024
1. VERGALLO R, Volpe M
   Lowering dietary sodium intake to reduce blood pressure: cum grano salis.
   Eur Heart J. 2024;45:1301-1302.
   PubMed    
   
   
   March 2024
2. PITRE T, Weatherald J, Humbert M
   Treatments for pulmonary arterial hypertension: navigating through a network of choices.
   Eur Heart J. 2024 Mar 5:ehae106. doi: 10.1093.
   PubMed    
   
   
   
3. MA E, Wo D, Chen J, Yan H, et al
   Inhibition of a novel Dickkopf-1-LDL receptor-related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice.
   Eur Heart J. 2024;45:688-703.
   PubMed     Abstract available
   
   
   February 2024
4. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
   Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
   Eur Heart J. 2024 Feb 28:ehae049. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. RUILOPE LM, Ortiz A, Ruiz-Hurtado G
   Hypertension and the kidney: an update.
   Eur Heart J. 2024 Feb 8:ehad896. doi: 10.1093.
   PubMed    
   
   
   January 2024
6. GUPTA A, Whiteley WN, Godec T, Rostamian S, et al
   Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
   Eur Heart J. 2024 Jan 31:ehad814. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2023
7. TOTH PP
   Dickkopf-1: an emerging danger signal in hypertension and cardiovascular disease.
   Eur Heart J. 2023 Dec 29:ehad797. doi: 10.1093.
   PubMed    
   
   
   
8. HE Z, Zhang D, Wang X
   Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
   Eur Heart J. 2023 Dec 28:ehad862. doi: 10.1093.
   PubMed    
   
   
   
9. LI XM, Zhu XJ, Jing ZC
   Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
   Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
   PubMed    
   
   
   
10. O'DONNELL M, Yusuf S, Vogt L, Mente A, et al
    Potassium intake: the Cinderella electrolyte.
    Eur Heart J. 2023;44:4925-4934.
    PubMed     Abstract available
    
    
    
11. SCHNEIDER SR, Muller J, Bauer M, Mayer L, et al
    Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.
    Eur Heart J. 2023 Dec 11:ehad789. doi: 10.1093.
    PubMed    
    
    
    November 2023
12. VOLPE M, Galiuto L
    More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostat.
    Eur Heart J. 2023 Nov 9:ehad756. doi: 10.1093.
    PubMed    
    
    
    
13. TSCHIDERER L, van der Schouw YT, Burgess S, Bloemenkamp KW, et al
    Hypertensive disorders of pregnancy and cardiovascular disease risk: A Mendelian Randomisation study.
    Eur Heart J. 2023;44.
    PubMed     Abstract available
    
    
    
14. GALIE N, Palazzini M, Manes A
    Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds.
    Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093.
    PubMed    
    
    
    
15. ACKLAND GL, Patel A, Abbott TEF, Begum S, et al
    Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.
    Eur Heart J. 2023 Nov 7:ehad716. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
16. BRAUNWALD E
    Inhibition of angiotensinogen in the treatment of hypertension.
    Eur Heart J. 2023 Oct 27:ehad704. doi: 10.1093.
    PubMed    
    
    
    September 2023
17. LIU JN, Zhao ZG, Luo FM
    Pulmonary hypertension-related dynamic left ventricular outflow tract obstruction.
    Eur Heart J. 2023 Sep 19:ehad605. doi: 10.1093.
    PubMed    
    
    
    
18. LIUZZO G, Volpe M
    Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challenges.
    Eur Heart J. 2023 Sep 8:ehad593. doi: 10.1093.
    PubMed    
    
    
    August 2023
19. KARIA N, Howard L, Johnson M, Kiely DG, et al
    Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Eur Heart J. 2023 Aug 24:ehad532. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. ZHENG X, Cao J, Zhang G
    Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister.
    Eur Heart J. 2023 Aug 9:ehad505. doi: 10.1093.
    PubMed    
    
    
    
22. LIUZZO G, Volpe M
    24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?
    Eur Heart J. 2023;44:2802-2804.
    PubMed    
    
    
    
23. CREA F
    Focus on translational vascular biology: new therapeutic targets in hypertension, aortic aneurysm, and atherosclerosis.
    Eur Heart J. 2023;44:2645-2649.
    PubMed    
    
    
    July 2023
24. LANG IM, Andreassen AK, Andersen A, Bouvaist H, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.
    Eur Heart J. 2023 Jul 20:ehad413. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
25. LU X, Wen P, Xing Q
    Hypertension secondary to renal hypoplasia in a child.
    Eur Heart J. 2023 Jun 28:ehad409. doi: 10.1093.
    PubMed    
    
    
    
26. ZHUANG T, Lei Y, Chang JJ, Zhou YP, et al
    A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension.
    Eur Heart J. 2023 Jun 28:ehad377. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. NOSALSKI R, Guzik TJ
    Skin sodium, lymphatics, and blood pressure: a non-canonical mechanism of salt-sensitive hypertension.
    Eur Heart J. 2023 Jun 28:ehad290. doi: 10.1093.
    PubMed    
    
    
    
28. CREA F
    Focus on the complex relationships among hypertension, dementia, and comorbidities.
    Eur Heart J. 2023;44:2051-2054.
    PubMed    
    
    
    
29. LANG IM, Delcroix M
    Novel acquisitions in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2023 Jun 15:ehad314. doi: 10.1093.
    PubMed    
    
    
    
30. MARTENS P, Yu S, Larive B, Borlaug BA, et al
    Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
    Eur Heart J. 2023;44:1979-1991.
    PubMed     Abstract available
    
    
    
31. 
    Correction to: Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Eur Heart J. 2023 Jun 7:ehad321. doi: 10.1093.
    PubMed    
    
    
    May 2023
32. PITT B, Bakris GL
    Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade.
    Eur Heart J. 2023 May 24:ehad299. doi: 10.1093.
    PubMed    
    
    
    
33. RAM CVS
    'Normal' blood pressure is no longer a safe haven: take shelter under 'optimal' blood pressure.
    Eur Heart J. 2023;44:1674-1675.
    PubMed    
    
    
    
34. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    PubMed     Abstract available
    
    
    April 2023
35. ELHAKEEM A, Taylor AE, Inskip HM, Huang JY, et al
    Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysis.
    Eur Heart J. 2023;44:1464-1473.
    PubMed     Abstract available
    
    
    
36. CREA F
    Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension.
    Eur Heart J. 2023;44:1193-1196.
    PubMed    
    
    
    March 2023
37. SCHIFFRIN EL, Engert JC
    Hypertension, brain imaging phenotypes, and cognitive impairment: lessons from Mendelian randomization.
    Eur Heart J. 2023 Mar 30:ehad187. doi: 10.1093.
    PubMed    
    
    
    
38. SIEDLINSKI M, Carnevale L, Xu X, Carnevale D, et al
    Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure.
    Eur Heart J. 2023 Mar 27:ehad101. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
39. 
    Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respi
    Eur Heart J. 2023 Feb 23:ehad005. doi: 10.1093.
    PubMed    
    
    
    
40. VOLPE M, Gallo G, Rubattu S
    Endocrine functions of the heart: from bench to bedside.
    Eur Heart J. 2023;44:643-655.
    PubMed     Abstract available
    
    
    
41. VISWANATHAN G, Rajagopal S
    De novo purine synthesis: a new target in pulmonary arterial hypertension?
    Eur Heart J. 2023 Feb 20:ehad078. doi: 10.1093.
    PubMed    
    
    
    
42. BARBATO E, Azizi M, Schmieder RE, Lauder L, et al
    Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Eur Heart J. 2023 Feb 15:ehad054. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. VOLPE M, Liuzzo G
    The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?
    Eur Heart J. 2023 Feb 14:ehad077. doi: 10.1093.
    PubMed    
    
    
    
44. ROSENKRANZ S, Delcroix M, Giannakoulas G, Hoeper MM, et al
    The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    Eur Heart J. 2023 Feb 1:ehad018. doi: 10.1093.
    PubMed    
    
    
    January 2023
45. MA Q, Yang Q, Xu J, Sellers HG, et al
    Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
    Eur Heart J. 2023 Jan 31:ehad044. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
46. PETERS R, Xu Y, Fitzgerald O, Aung HL, et al
    Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis.
    Eur Heart J. 2022;43:4980-4990.
    PubMed     Abstract available
    
    
    
47. VOLPE M, Patrono C
    The promise of selective aldosterone synthase inhibition for the management of resistant hypertension.
    Eur Heart J. 2022 Dec 20:ehac754. doi: 10.1093.
    PubMed    
    
    
    
48. CREA F
    Physical exercise, inflammation, and hypertension: how to improve cardiovascular prevention.
    Eur Heart J. 2022;43:4763-4766.
    PubMed    
    
    
    
49. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
50. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. LAUDER L, Mahfoud F, Azizi M, Bhatt DL, et al
    Hypertension management in patients with cardiovascular comorbidities.
    Eur Heart J. 2022 Nov 7. pii: 6808663. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. SCHUTTE AE
    The promise and pitfalls of novel cuffless blood pressure devices.
    Eur Heart J. 2022;43:4222-4223.
    PubMed    
    
    
    October 2022
53. CREA F
    Update on a silent killer: arterial hypertension.
    Eur Heart J. 2022;43:3595-3598.
    PubMed    
    
    
    
54. RIVASI G, Groppelli A, Brignole M, Soranna D, et al
    Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study.
    Eur Heart J. 2022;43:3765-3776.
    PubMed     Abstract available
    
    
    September 2022
55. GERDTS E, Sudano I, Brouwers S, Borghi C, et al
    Sex differences in arterial hypertension.
    Eur Heart J. 2022 Sep 22. pii: 6711154. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. CREA F
    Hypertension in children, adolescents, and pregnant women: challenges and opportunities.
    Eur Heart J. 2022;43:3275-3278.
    PubMed    
    
    
    
57. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines.
    Eur Heart J. 2022;43:3302-3311.
    PubMed     Abstract available
    
    
    August 2022
58. HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
    2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    Eur Heart J. 2022 Aug 26. pii: 6673929. doi: 10.1093.
    PubMed    
    
    
    
59. WENZEL P
    Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis.
    Eur Heart J. 2022 Aug 18. pii: 6671020. doi: 10.1093.
    PubMed    
    
    
    
60. PANDEY AK, Bhatt DL, Cosentino F, Marx N, et al
    Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
    Eur Heart J. 2022;43:2931-2945.
    PubMed     Abstract available
    
    
    
61. UMEI TC, Kishino Y, Kawakami T, Fukuda K, et al
    Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2022 Aug 8. pii: 6658235. doi: 10.1093.
    PubMed    
    
    
    
62. WOUDA RD, Boekholdt SM, Khaw KT, Wareham NJ, et al
    Sex-specific associations between potassium intake, blood pressure, and cardiovascular outcomes: the EPIC-Norfolk study.
    Eur Heart J. 2022;43:2867-2875.
    PubMed     Abstract available
    
    
    
63. JOSEPH P, Kutty VR, Mohan V, Kumar R, et al
    Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
    Eur Heart J. 2022;43:2831-2840.
    PubMed     Abstract available
    
    
    
64. LI S, Liu Z, Joseph P, Hu B, et al
    Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
    Eur Heart J. 2022;43:2852-2863.
    PubMed     Abstract available
    
    
    
65. PRESCOTT E
    Lessons from PURE on modifiable risk.
    Eur Heart J. 2022;43:2864-2866.
    PubMed    
    
    
    
66. LOPEZ-JARAMILLO P, Joseph P, Lopez-Lopez JP, Lanas F, et al
    Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
    Eur Heart J. 2022;43:2841-2851.
    PubMed     Abstract available
    
    
    
67. CAULDWELL M
    Understanding the implications of hypertensive disorders in pregnancy in women with heart disease.
    Eur Heart J. 2022 Aug 3. pii: 6653698. doi: 10.1093.
    PubMed    
    
    
    
68. DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
    Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
    Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. BAUERSACHS J, Olsson KM
    Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
    Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.
    PubMed    
    
    
    July 2022
70. DE SIMONE G, Mancusi C, Hanssen H, Genovesi S, et al
    Hypertension in children and adolescents.
    Eur Heart J. 2022 Jul 27. pii: 6633855. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. TADIC M, Cuspidi C, Marwick TH
    Phenotyping the hypertensive heart.
    Eur Heart J. 2022 Jul 23. pii: 6648534. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. VERGALLO R, Volpe M
    Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up.
    Eur Heart J. 2022;43:2655-2656.
    PubMed    
    
    
    
73. OMOTE K, Sorimachi H, Obokata M, Reddy YNV, et al
    Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Eur Heart J. 2022 Jul 7. pii: 6633254. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. HOEPER MM, Rosenkranz S
    Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
    Eur Heart J. 2022 Jul 7. pii: 6633248. doi: 10.1093.
    PubMed    
    
    
    June 2022
75. RAMLAKHAN KP, Malhame I, Marelli A, Rutz T, et al
    Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.
    Eur Heart J. 2022 Jun 21. pii: 6612238. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
76. LUCAS-HERALD AK, Montezano AC, Alves-Lopes R, Haddow L, et al
    Vascular dysfunction and increased cardiovascular risk in hypospadias.
    Eur Heart J. 2022;43:1832-1845.
    PubMed     Abstract available
    
    
    
77. GALIUTO L, Volpe M
    Treatment of mild hypertension improves pregnancy outcomes.
    Eur Heart J. 2022 May 13. pii: 6585107. doi: 10.1093.
    PubMed    
    
    
    
78. SCHUTTE AE, Neal B
    The sodium hidden in medication: a tough pill to swallow.
    Eur Heart J. 2022;43:1756-1758.
    PubMed    
    
    
    April 2022
79. VALERIO L, Mavromanoli AC, Barco S, Abele C, et al
    Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
    Eur Heart J. 2022 Apr 28. pii: 6575686. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. OJJI D, Aifah A, Dulli L, Iwelunmor J, et al
    Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT).
    Eur Heart J. 2022 Apr 20. pii: 6571044. doi: 10.1093.
    PubMed    
    
    
    March 2022
81. VOLPE M, Patrono C
    Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes.
    Eur Heart J. 2022;43:1189-1190.
    PubMed    
    
    
    February 2022
82. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. RAM CVS
    Renal denervation therapy for hypertension: all that glitters is not gold.
    Eur Heart J. 2022 Feb 15. pii: 6529363. doi: 10.1093.
    PubMed    
    
    
    
84. VOLPE M, Patrono C
    Age-independent benefits of blood pressure lowering: are they applicable to all patients?
    Eur Heart J. 2022;43:448-449.
    PubMed    
    
    
    
85. MESSERLI FH, Siontis GCM, Bavishi C, Messerli AW, et al
    Importance of pulse pressure at low systolic blood pressure.
    Eur Heart J. 2022;43:540.
    PubMed    
    
    
    
86. SPENCE JD, Muller LO, Blanco PJ
    How to identify which patients should not have a systolic blood pressure target of <120 mmHg.
    Eur Heart J. 2022;43:538-539.
    PubMed    
    
    
    
87. CORRAO G, Mancia G
    Research strategies in treatment of hypertension: value of retrospective real-life data.
    Eur Heart J. 2022 Feb 3. pii: 6520830. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
88. VOLPE M, Patrono C
    Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
    Eur Heart J. 2021;42:4885-4886.
    PubMed    
    
    
    
89. VOLPE M, Patrono C
    Another STEP towards tighter control of blood pressure in the elderly.
    Eur Heart J. 2021;42:4715-4716.
    PubMed    
    
    
    October 2021
90. MIHAILIDOU AS, Gulati M
    Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.
    Eur Heart J. 2021 Oct 18. pii: 6399973. doi: 10.1093.
    PubMed    
    
    
    
91. BOUCHERON P, Lailler G, Moutengou E, Regnault N, et al
    Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study.
    Eur Heart J. 2021 Oct 13. pii: 6395270. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
92. RUILOPE LM, Valenzuela PL, Lucia A
    Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
    Eur Heart J. 2021 Sep 27. pii: 6377082. doi: 10.1093.
    PubMed    
    
    
    
93. CREA F
    The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy.
    Eur Heart J. 2021;42:3581-3585.
    PubMed    
    
    
    
94. FUKUMOTO Y
    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.
    PubMed    
    
    
    
95. LINZ D, Gawalko M, Sanders P, Penders J, et al
    Does gut microbiota affect atrial rhythm? Causalities and speculations.
    Eur Heart J. 2021;42:3521-3525.
    PubMed     Abstract available
    
    
    
96. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed    
    
    
    
97. JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
    Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
    Eur Heart J. 2021 Sep 10. pii: 6368314. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.
    Eur Heart J. 2021 Sep 4. pii: 6364086. doi: 10.1093.
    PubMed    
    
    
    August 2021
100. KARIO K, Nomura A, Harada N, Okura A, et al
     Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
     Eur Heart J. 2021 Aug 29. pii: 6358480. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. VOLPE M, Gallo G
     Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
     Eur Heart J. 2021 Aug 15. pii: 6352588. doi: 10.1093.
     PubMed    
     
     
     
102. JACKSON AM, Jhund PS, Anand IS, Dungen HD, et al
     Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
     Eur Heart J. 2021 Aug 15. pii: 6352587. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2021
103. VOLPE M, Patrono C
     The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile.
     Eur Heart J. 2021;42:2814-2815.
     PubMed    
     
     
     June 2021
104. VOLPE M, Patrono C
     A SPRINT towards tighter control of blood pressure in hypertension.
     Eur Heart J. 2021 Jun 25. pii: 6309731. doi: 10.1093.
     PubMed    
     
     
     
105. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
     Salt reduction to prevent hypertension: the reasons of the controversy.
     Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. MESSERLI FH, Brguljan J, Rexhaj E, Sever P, et al
     Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.
     Eur Heart J. 2021;42:2052-2059.
     PubMed    
     
     
     
107. YAN Y, Mu J
     Salt intake paradox: the estimation method matters.
     Eur Heart J. 2021;42:2133.
     PubMed    
     
     
     May 2021
108. LANDMESSER U, Lehmann I, Eils R
     Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
     Eur Heart J. 2021;42:1720-1721.
     PubMed    
     
     
     April 2021
109. 
     Erratum to: A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
     Eur Heart J. 2021 Apr 13. pii: 6224359. doi: 10.1093.
     PubMed    
     
     
     March 2021
110. VAN DIEPEN S, Armstrong PW
     Learning whether to subtract beta-blockers: it's about time.
     Eur Heart J. 2021;42:915-918.
     PubMed     Abstract available
     
     
     February 2021
111. ESTRUCH R, Ruilope LM, Cosentino F
     The year in cardiovascular medicine 2020: epidemiology and prevention.
     Eur Heart J. 2021;42:813-821.
     PubMed    
     
     
     
112. WARTOLOWSKA KA, Webb AJS
     Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
     Eur Heart J. 2021;42:750-757.
     PubMed     Abstract available
     
     
     November 2020
113. LIEW CH, McEvoy JW
     The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
     Eur Heart J. 2020;41:4284-4285.
     PubMed    
     
     
     
114. VOLPE M, Patrono C
     Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data.
     Eur Heart J. 2020;41:3986-3987.
     PubMed    
     
     
     March 2020
115. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
     Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
     Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2019
116. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
     Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
     Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.